Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…
Biotechnology
US, Tarrytown [HQ]
News
Theses · Events · SentimentsSentiments
Regeneron shares fell 9.2% after the Q3 2024 report, making the company's valuation more attractive. The strong report was the …
Shares of Regeneron are in free fall after recent litigation setbacks on Eylea and with Amgen launching a biosimilar low-dose …